No Data
No Data
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading
LifeSci Capital Initiates Coverage On Mereo BioPharma Group With Outperform Rating, Announces Price Target of $10
LifeSci Capital Initiates Mereo BioPharma(MREO.US) With Buy Rating, Announces Target Price $10
Mereo Biopharma's Potential in Rare Disease Therapy: Buy Rating and Strategic Partnership With Ultragenyx
Crude Oil Down 1%; Webuy Global Shares Spike Higher
Mereo BioPharma Shares Rise After Jefferies Begins Coverage at Buy
No Data